All terms in GO
| Label | Id | Description |
|---|---|---|
| cellular response to interleukin-9 | GO_0071355 | [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-9 stimulus.] |
| nodal signaling pathway involved in determination of left/right asymmetry | GO_0038107 | [A series of molecular signals initiated by the binding of a nodal protein to an activin receptor on the surface of a target cell, which contributes to the establishment of an organism's body plan or part of an organism with respect to the left and right halves.] |
| nodal signaling pathway | GO_0038092 | [A series of molecular signals initiated by the binding of a nodal protein to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.] |
| regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry | GO_1900094 | [Any regulation of transcription from RNA polymerase II promoter that is involved in determination of left/right symmetry.] |
| negative regulation of appetite by leptin-mediated signaling pathway | GO_0038108 | [A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, which reduces appetite, the desire or physical craving for food.] |
| negative regulation of appetite | GO_0032099 | [Any process that reduces appetite.] |
| leptin-mediated signaling pathway | GO_0033210 | [A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body.] |
| cellular response to stem cell factor stimulus | GO_0036216 | [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stem cell factor (SCF) stimulus.] |
| activin receptor antagonist activity involved in negative regulation of nodal signaling pathway | GO_0038103 | [Interacting with an activin receptor to reduce the action of the agonist nodal. A receptor antagonist does not initiate signaling upon binding to a receptor, but instead blocks an agonist from binding to the receptor.] |
| activin receptor antagonist activity | GO_0038102 | [Interacting with an activin receptor complex to reduce the action of another ligand, the agonist. A receptor antagonist does not initiate signaling upon binding to a receptor, but instead blocks an agonist from binding to the receptor.] |
| negative regulation of nodal signaling pathway | GO_1900108 | [Any process that stops, prevents or reduces the frequency, rate or extent of nodal signaling pathway.] |
| nodal receptor complex | GO_0038104 | [A protein complex containing at least a type II activin receptor, a type I activin receptor, and a coreceptor (EGF-CFC protein) such as Cripto or Cryptic. Nodal receptor complexes are capable of binding a nodal protein and transducing the signal into the cell.] |
| sequestering of TGFbeta from receptor via TGFbeta binding | GO_0038105 | [Binding to a transforming growth factor-beta (TGFbeta) protein in the extracellular region, and inhibiting TGFbeta signaling by preventing TGFbeta from binding to its cell surface receptor.] |
| sequestering of extracellular ligand from receptor | GO_0035581 | [The process of binding or confining an extracellular signaling ligand, such that the ligand is unable to bind to its cell surface receptor.] |
| choriogonadotropin hormone binding | GO_0038106 | [Interacting selectively and non-covalently with choriogonadotropin hormone, a heterodimer, with an alpha subunit identical to that of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH), and a unique beta subunit.] |
| nodal binding | GO_0038100 | [Interacting selectively and non-covalently with a nodal protein, a member of the transforming growth factor-beta superfamily.] |
| sequestering of nodal from receptor via nodal binding | GO_0038101 | [Binding to a nodal protein in the extracellular region, and inhibiting nodal signaling by preventing nodal from binding to its cell surface receptor.] |
| negative regulation of activin receptor signaling pathway | GO_0032926 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.] |
| ERBB3-ERBB4 signaling pathway | GO_0038136 | [A series of molecular signals transmitted by a heterodimeric complex of the tyrosine kinase receptors ERBB3 and ERBB4. The pathway begins with binding of a ligand to either cell surface receptor, or the dimeric receptor complex, and ends with regulation of a downstream cellular process, e.g. transcription.] |
| ERBB3 signaling pathway | GO_0038129 | [A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor ERBB3 on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription. ERBB3 receptors have impaired kinase activity and rely on the kinase activity of the heterodimer partner for activation and signal transmission.] |